Monthly Prescribing Reference

Birth Control Patch With Lower Estrogen Dose Effective in Phase 3 Trial

The Company expects to submit the New Drug Application for Xulane Lo in the second half of 2025. A low dose combination hormonal patch was found to be effective for pregnancy prevention based on ...
Time

Did Johnson & Johnson Bury Data on Ortho-Evra’s Health Risks?

It’s should be common knowledge that the Johnson & Johnson (J&J) Ortho-Evra birth-control patch has more risks than the birth control pill (it’s on the label) — because it exposes women to higher ...
NBC DFW

Did Drugmaker Hide Birth Control Patch Risks?

Pharmaceutical giant Johnson & Johnson may have known years ago about the deadly risks of its birth control patch Ortho Evra, according to internal documents obtained by NBC News. Patient reports ...
Seeking Alpha

Viatris Announces Positive Results from Phase 3 Study of Investigational XULANE LO™ Low Dose Patch for Birth Control in Women of Childbearing Potential

PITTSBURGH, May 8, 2025 /PRNewswire/ -- Viatris Inc. (VTRS) (Nasdaq: VTRS), a global healthcare company, today announced positive results of its Phase 3 study (NCT05139121) evaluating the ...
Hosted on MSN

When Will You Get Your First Period After Stopping Birth Control?

More than 65 percent of women ages 15 to 49 in the United States use some form of birth control, and many of them are on hormonal birth control methods like the pill, patch, ring, implant, injections, ...